FDA
-
-
-
-
-
-
-
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
-
-
-
-
-
-
-
FDA selects 7 companies for domestic drug manufacturing pilot
-
-
-
-
-
-
-
FDA approves AbbVie's Skyrizi for children with psoriatic disease
-
-
-
-
-
-
-
Allergan Aesthetics Receives U.S. FDA Approval for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance
-
-
-
-
-
-
-
Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
-
-
-
-
-
-
-
US FDA declines to approve AbbVie's wrinkle treatment due to manufacturing concerns (April 23)
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Abbvie (ABBV)
-
327,505 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

